Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04787991
Title Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)
Acronym REVOLUTION
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Parker Institute for Cancer Immunotherapy
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.